Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Contents:; Biologics and the need for biosimilars -- Why do we need biosimilars? -- How is the quality of biosimilar medicines assured? -- Legal issues -- Switching, interchangeability and extrapolation -- Safety and pharmacovigilant -- Global issues -- Formulary considerations: pharmacy issues -- …
Introduction; Identification of abnormal B-cell populations; Identification of abnormal T-cell populations; Antigen expression during myeloid and lymphoid differentiation; Identification of blasts; Immunophenotypic features of dyspoiesis in maturing myeloid and monocytic neoplasms; Flow cytometry l…
c.1 BC Cancer Agency VAN Library | Available |